LSE - Delayed Quote GBp

Avacta Group Plc (AVCT.L)

34.00
-0.50
(-1.45%)
At close: May 15 at 4:38:31 PM GMT+1
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for AVCT.L

Recent News: AVCT.L

View More
Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
GlobeNewswire 17 days ago
Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting

Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting
GlobeNewswire 17 days ago
Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives

Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives
GlobeNewswire last month
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting

Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
GlobeNewswire last month
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference

Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
GlobeNewswire 2 months ago
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts

Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
GlobeNewswire 2 months ago
Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer

Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer
Clinical Trials Arena 3 months ago
While institutions own 41% of Avacta Group Plc (LON:AVCT), individual investors are its largest shareholders with 57% ownership

While institutions own 41% of Avacta Group Plc (LON:AVCT), individual investors are its largest shareholders with 57% ownership
Simply Wall St. 4 months ago
Investors in Avacta Group (LON:AVCT) have seen splendid returns of 163% over the past five years

Investors in Avacta Group (LON:AVCT) have seen splendid returns of 163% over the past five years
Simply Wall St. 5 months ago
Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona
GlobeNewswire 6 months ago
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
GlobeNewswire 6 months ago
View More

Related Tickers

BSFA.L BSF Enterprise Plc
2.2500
-2.17%
 
FARN.L Faron Pharmaceuticals Oy
225.00
0.00%
 
BSFAF BSF Enterprise Plc
0.0350
+75.00%
 
FUM.L Futura Medical plc
8.70
-1.36%
 
HVO.L hVIVO plc
18.13
+2.11%
 
OXB.L Oxford Biomedica plc
296.00
+2.07%
 
ONT.L Oxford Nanopore Technologies plc
127.50
-1.09%
 
F6T.DU Fate Therapeutics Inc
0.9182
+7.29%
 
1CVAC.MI CureVac N.V.
3.0600
+0.13%
 
ABRT.CN Albert Labs International Corp.
0.0050
0.00%